Psychotropics in the next edition of the Interagency Emergency Health Kit [1].

a<p>The three anti-convulsants are phenobarbital (1,000 50-mg tablets), diazepam (200 injections, 5 mg/ml; 2 ml/ampoule), and magnesium sulfate (40 injections; 500 mg/ml; 10 ml/ampoule).</p>b<p>The five psychotherapeutic medicines are amitriptyline (4,000 25-mg tablets); biperiden (400 2-mg tablets), diazepam (240 5-mg tablets), haloperidol (1,300 5-mg tablets), and haloperidol (20 injections; 5 mg/ml; 1 ml/ampoule).</p

The WHO Model List of Essential Medicines and the Interagency Emergency Health Kit (IEHK).

a<p>Indicates that the medicine represents a pharmacological class (similar clinical performance).</p

Advantages and disadvantages of including fluoxetine versus amitriptyline in the Interagency Emergency Health Kit (IEHK).

<p>Advantages and disadvantages of including fluoxetine versus amitriptyline in the Interagency Emergency Health Kit (IEHK).</p

Violence against women assessed at baseline.

<p>Violence against women assessed at baseline.</p

Participant characteristics and trauma exposure assessed at baseline.

<p>Participant characteristics and trauma exposure assessed at baseline.</p

Estimated mean scores for primary and secondary outcome measures at baseline, posttreatment, and 3-month follow-up for women with a history of gender-based violence.

<p>Estimated mean scores for primary and secondary outcome measures at baseline, posttreatment, and 3-month follow-up for women with a history of gender-based violence.</p

Estimated means of primary and secondary outcomes.

<p>Values based on estimated means derived from hierarchical linear model analyses. Error bars indicate 95% confidence intervals. EUC, enhanced usual care; GHQ, General Health Questionnaire; PCL, Posttraumatic Stress Disorder Checklist; PM+, Problem Management Plus; PSYCHLOPS, Personalized Outcome Profiles; WHODAS, WHO Disability Adjustment Scale.</p

Quality assessments by outcome as percentages across all included systematic reviews with meta-analyses.

P(I)ECO, Population, (Intervention) or Exposure, Comparator, Outcome; RoB, Risk of Bias.</p

Characteristics of included systematic reviews with meta-analyses.

Characteristics of included systematic reviews with meta-analyses.</p

Cross-sectional pooled prevalence rates of above cut-offs of symptoms of depression during COVID-19 pandemic in general populations.

Pooled prevalence rates from cross-sectional studies in general population with 95% confidence intervals.</p